Tata Sons is working to merge subsidiaries into the parent company to potentially exit the RBI's 'Upper Layer' NBFC classification and avoid mandatory listing. Separately, Anupam Rasayan acquired a 48.2% stake in Bliss GVS Pharma, while several infrastructure firms, including NCC and IRFC, secured new project contracts.
Tata Sons is exploring a structural overhaul involving the merger of subsidiaries, such as Tata Electronics Systems Solutions and Tata Consulting Engineers, into the parent holding company. This strategic move aims to alter the company's financial composition, potentially allowing it to exit the 'Upper Layer' Non-Banking Financial Company (NBFC) framework set by the Reserve Bank of India.
In 2022, the central bank classified Tata Sons as an Upper Layer NBFC due to its size and systemic importance. This classification brings strict regulatory oversight, including mandatory listing requirements on stock exchanges. The group has historically sought to avoid this listing mandate, maintaining that it functions primarily as a core holding company for the group's operating firms rather than a traditional financial lender. However, the RBI has previously rejected requests for the voluntary surrender of this registration, as the regulator prioritizes financial stability and governance oversight for systemically important entities. Success for this plan depends on whether the revised business structure satisfies the central bank that the entity no longer poses the risks associated with the current NBFC classification.
For investors, this development is significant. Tata Sons holds major stakes in group giants like TCS, Tata Motors, and Tata Steel. Any shift in the parent company's regulatory or listing status could have long-term implications for the group's capital allocation and corporate structure. Investors may track the progress of these discussions with the regulator, as the RBI's stance remains the critical factor for any potential reclassification.
Separately, the corporate sector saw significant deal activity. Anupam Rasayan India finalized the acquisition of a 48.2% controlling stake in Bliss GVS Pharma at ₹299 per share. This transaction marks a shift for the chemical manufacturer into the finished dosage formulations segment. The acquisition was funded through a combination of debt and non-voting instruments. As the company diversifies into a new business model, stakeholders may monitor the impact of this expansion on the firm's debt levels and operational margins.
Infrastructure and industrial activity also recorded new momentum. The Indian Railway Finance Corporation (IRFC) entered into a ₹4,200-crore financing agreement with Damodar Valley Corporation to support renewable energy projects. In the construction space, NCC Limited secured a ₹1,076.71 crore contract from the Andhra Pradesh government for a multi-village drinking water scheme. Additionally, Power Mech Projects reported a ₹279.20 crore operation and maintenance order from the Telangana Power Generation Corporation, and Ellenbarrie Industrial Gases received a ₹481 crore order from BHEL. These contracts underscore the ongoing capital spending trends across power and public infrastructure sectors.